London Biotechnology Show 2026 Connects Industry Buyers, Suppliers, Innovators Through Dedicated Business Programme
The London Biotechnology Show 2026 concluded at ExCeL
London after two days of industry engagement.
LONDON, November 19: The London Biotechnology Show 2026 concluded at ExCeL
London after two days of industry engagement, with its Hosted Buyer Programme and
international exhibition providing dedicated opportunities for businesses, buyers and
technology providers to explore commercial connections across the life sciences sector.
The third edition of the event brought together pharmaceutical and biotechnology
companies, research institutions, healthcare organisations, investors, manufacturers and
specialist solution providers, creating a setting for discussions around procurement,
technology adoption, partnerships and business development.
A central feature was the Hosted Buyer Programme, designed to connect qualified buyers
and senior decision-makers with participating exhibitors through pre-arranged business
meetings. The initiative aimed to facilitate focused conversations between organisations
seeking biotechnology products, services and solutions and companies offering capabilities
across the sector.
The exhibition featured a diverse range of organisations, including Merck, Thermo Fisher
Scientific, FUJIFILM Biosciences, Foxx Life Sciences, Gerresheimer, Abcam, Novogene,
Vector Laboratories, Automata and other specialist providers.
Their participation reflected the breadth of the biotechnology supply chain, encompassing
laboratory equipment, research technologies, life sciences manufacturing, diagnostics,
bioprocessing and specialist services.
The Startup Showcase added another dimension to the business programme, giving
emerging companies an opportunity to present their innovations and engage with potential
investors, buyers and strategic partners.
The event was supported by industry associations, regional innovation clusters and
professional organisations, including the BioIndustry Association, MedCity, Bionow,
BioPartner UK, Health Tech Alliance, One HealthTech, Medicon Valley Alliance, Biocat,
AseBio, Hollandbio and P-BIO.
Their involvement highlighted the importance of collaboration between businesses, research
institutions, industry networks and investment communities in strengthening the international life sciences ecosystem.
As biotechnology continues to attract investment and drive innovation across healthcare and
industrial applications, the London Biotechnology Show provided a platform for stakeholders
to identify potential areas of cooperation and explore opportunities across the global market.
The event concluded on 19 November following two days of conference sessions, exhibition
activity and business engagement.

Author
BioFocus Newsroom


